Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis
about
Glucagon-like peptide analogues for type 2 diabetes mellitusGlucagon-like peptide analogues for type 2 diabetes mellitusGlucagon-like peptide-1 activation of TCF7L2-dependent Wnt signaling enhances pancreatic beta cell proliferationDiabetes outfoxed by GLP-1?Endogenous and synthetic agonists of GPR119 differ in signalling pathways and their effects on insulin secretion in MIN6c4 insulinoma cellsMechanisms of action of glucagon-like peptide 1 in the pancreasGlucagon-like peptide-1 and cholecystokinin production and signaling in the pancreatic islet as an adaptive response to obesityPancreatic regulation of glucose homeostasisInterventions to preserve beta-cell function in the management and prevention of type 2 diabetesThe required beta cell research for improving treatment of type 2 diabetesGLP-1, the gut-brain, and brain-periphery axesTranslational implications of the β-cell epigenome in diabetes mellitusThe effects of exendin-4 treatment on graft failure: an animal study using a novel re-vascularized minimal human islet transplant modelNutritional modulation of endogenous glucagon-like peptide-1 secretion: a reviewDipeptidyl peptidase-4 inhibitor attenuates hepatic fibrosis via suppression of activated hepatic stellate cell in ratsNovel GLP-1 fusion chimera as potent long acting GLP-1 receptor agonistProtection of glucagon-like peptide-1 in cisplatin-induced renal injury elucidates gut-kidney connection.Lipotoxicity disrupts incretin-regulated human β cell connectivityImproved glycemic control and reduced bodyweight with exenatide: A double-blind, randomized, phase 3 study in Japanese patients with suboptimally controlled type 2 diabetes over 24 weeksGlucagon-like peptide-1 analog liraglutide in combination with sulfonylurea safely improves blood glucose measures vs sulfonylurea monotherapy in Japanese patients with type 2 diabetes: Results of a 52-week, randomized, multicenter trial.Combination treatment of db/db mice with exendin-4 and gastrin preserves β-cell mass by stimulating β-cell growth and differentiation.Glucose-dependent insulinotropic polypeptide signaling in pancreatic β-cells and adipocytesGLP-1(28-36)amide, the Glucagon-like peptide-1 metabolite: friend, foe, or pharmacological folly?Glucagon-like peptide analogues for type 2 diabetes mellitus: systematic review and meta-analysisDo Incretins play a role in the remission of type 2 diabetes after gastric bypass surgery: What are the evidence?Hyperglucagonemia in an animal model of insulin- deficient diabetes: what therapy can improve it?The human glucagon-like peptide-1 analogue liraglutide preserves pancreatic beta cells via regulation of cell kinetics and suppression of oxidative and endoplasmic reticulum stress in a mouse model of diabetes.Commonalities of genetic resistance to spontaneous autoimmune and free radical--mediated diabetes.Single dose GLP-1-Tf ameliorates myocardial ischemia/reperfusion injury.Receptors and effects of gut hormones in three osteoblastic cell linesGlucagon-like peptide-1 synthetic analogs: new therapeutic agents for use in the treatment of diabetes mellitus.Enhancing the GLP-1 receptor signaling pathway leads to proliferation and neuroprotection in human neuroblastoma cells.New insights concerning the glucose-dependent insulin secretagogue action of glucagon-like peptide-1 in pancreatic beta-cells.Cholecystokinin is up-regulated in obese mouse islets and expands beta-cell mass by increasing beta-cell survivalCOUP-TFII controls mouse pancreatic β-cell mass through GLP-1-β-catenin signaling pathwaysGLP-1 receptor stimulation reduces amyloid-beta peptide accumulation and cytotoxicity in cellular and animal models of Alzheimer's disease.Glucagon-like peptides 1 and 2 and vasoactive intestinal peptide are neuroprotective on cultured and mast cell co-cultured rat myenteric neuronsIncretin mimetics as pharmacologic tools to elucidate and as a new drug strategy to treat traumatic brain injuryRe-expression of IGF-II is important for beta cell regeneration in adult miceCREB mediates the insulinotropic and anti-apoptotic effects of GLP-1 signaling in adult mouse β-cells.
P2860
Q24235918-A68D4D4A-62F5-4BE1-AA68-5DA38D36671AQ24243685-DB28E5AB-53E2-4B51-82EC-988E17D02707Q24307581-7D8367F1-F058-49A8-A0A9-C83504AB4E78Q24603443-3D775902-D328-4EC2-BF45-D064542C6B8AQ24655150-C4BF7618-EBA0-4136-9700-E06F35B927CAQ24683764-BC9E3C24-904C-497A-BE78-52E1BDD1844AQ26749198-C8C631C3-2357-4A71-A522-ED19CC9BDC4AQ26766485-9A245ECF-00C0-43A3-9F9A-E7D9A23D6A28Q26830871-4910D743-D367-4903-B6F9-837A58C0D70CQ26851305-A6F23906-2492-45B8-A5DE-71ECB7246778Q27000749-470A0A20-EB27-4600-83B3-F85C6FAE8815Q27009451-7CECE8DC-84AD-48A6-AC52-623AC24C13D6Q27311069-7ABEB585-0A77-4D81-B8FA-AE81C0583DE3Q28070256-78F191C2-8D29-464C-B22C-427EE4020C4AQ28286911-A0F29C2D-B050-4D42-8B60-B0EEC208D9F0Q28475510-FD146B3B-4826-484B-905B-E656A55EC711Q30390165-BB90939F-0F5E-4C9A-9298-E035BA8A5FEDQ30634760-F1BEE10B-4C20-47BC-8C3D-F715950DE0EDQ33585633-0B7C209B-9B57-408F-9F60-B828A34BD9EFQ33585850-2657FFAD-FDD1-4628-B55D-18712E02A5DEQ33609727-EF7C2547-81FF-4D1A-A870-CCAA0DF54F01Q33609770-7CCFF699-405B-418A-959D-0484CEBAD809Q33734024-A6B1E237-898B-4FF2-8E33-2221B4AD9502Q33767049-A6CD4D7A-98D6-4701-90B3-ECFD6C0ACB36Q33789529-CB99EDA9-C5DC-4E0B-97F4-60E9DFB4ED32Q33801143-05B5441F-CA87-4277-9F1E-85AD19FEF5CDQ33826388-E918DD68-91F0-4C11-A9B3-B1203D7E4F60Q33857810-460215E5-70CC-4404-BA20-44C293B61616Q33925948-C3414C6F-A35B-4AE2-93CD-D50352345E6AQ33975451-07FC2A6E-E750-46F3-BD7C-EADCFD668DF8Q34026346-B0695F5E-6A40-4779-8950-1A61F0632ED1Q34028497-06EB61D6-141F-48B2-8D9E-3817DD331556Q34037472-9E40D183-7F50-4883-B63C-C583C17C72C7Q34132510-AFE78001-4309-4AB8-B202-E37F39F8DB95Q34146466-07529A00-8749-4F25-BABC-645E51FC52D7Q34167980-5E27BB5F-64F7-4238-8B39-A9C7C14E7B7CQ34215215-4931157C-2F27-4010-8E67-1F9268590052Q34362412-FB0BAA46-982D-4D8A-B5E0-35AA00F6993DQ34412090-B8CFB100-0A9B-44E1-87E3-76FF194A7877Q34436650-C54DDCA4-BF27-484B-BAD9-455F3AF9CC6B
P2860
Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis
description
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Journal of Biological Chemistry
@fr
artículu científicu espublizáu en 2003
@ast
im Januar 2003 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2003/01/03)
@sk
vědecký článek publikovaný v roce 2003
@cs
wetenschappelijk artikel (gepubliceerd op 2003/01/03)
@nl
наукова стаття, опублікована в січні 2003
@uk
name
Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis
@ast
Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis
@en
Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis
@nl
type
label
Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis
@ast
Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis
@en
Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis
@nl
prefLabel
Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis
@ast
Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis
@en
Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis
@nl
P2093
P3181
P356
P1476
Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis
@en
P2093
Bernardo Yusta
Frederic Ris
Philippe A. Halban
Tanya Hansotia
P304
P3181
P356
10.1074/JBC.M209423200
P407
P577
2003-01-03T00:00:00Z